Despite the efforts of scientists, the problems of premature aging, as well as diseases such as cancer, diabetes, herpes zoster, osteoporosis, and others still remain unresolved. Guanidine compounds have a strong effect on these processes. According to the mechano-chemiosmotic mechanism we have developed, energy transformation both in the synthesis and in the hydrolysis of ATP occurs with the direct participation of amino acid residues of arginine (a physiological compound of guanidine) and lysine. In addition, arginine and lysine are involved in many processes in the cell metabolism. Since arginine in the body is synthesized up to 28-30 years, we believe that aging begins with a decrease in arginine synthesis. After this age, it is necessary to maintain the arginine content in the organism by taking it exogenously, and the lysine content of an essential amino acid must be constantly replenished. For this purpose, we have developed and registered biologically active additives - the PULDIS energet R and PULDIS herpoff K preparations, containing L-arginine and L-lysine, respectively. In this regard, we offer a recipe for healthy longevity.
mechano-chemiosmotic mechanism, aging, disease, arginine, lysine
1. Lopez-Lazaro M. The Warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen? Anticancer Agents Med. Chem. journal, 2008, vol. 8, no. 3, pp. 305-312, DOI:https://doi.org/10.2174/187152008783961932.
2. Giang A-H., Raymond T., Brookes P., Bentley K.M., Schwarz E., O’Keefe R., Eliseev R. Mitochondrial dysfunction and permeability transition in osteosarcoma cells showing the Warburg effect. J Biol Chem., 2013, vol. 288, no. 46, pp. 33303-33311, DOI:https://doi.org/10.1074/jbc.M113.507129.
3. Vays V.B., Eldarov Ch.V., Vangely I.V., Kolosova N.G., Bakeeva L.E., Skulachev V.P. Antioxidant SkQ1 delays sarcopenia-associated damage of mitochondrial ultrastructure. Aging (Albany N.Y.), 2014, vol. 6, no. 2, 140-148, DOI:https://doi.org/10.18632/aging.100636.
4. Yu L.M., Zhang W.H., Han X.X., Li Y.Y., Lu Y. et al. Hypoxia-Induced ROS Contribute to Myoblast Pyroptosis during Obstructive Sleep Apnea via the NF-κB/HIF-1α Signaling Pathway. Oxid Med Cell Longev., 2019, pp. 1-19, DOI:https://doi.org/10.1155/2019/4596368.
5. Heß V., Kasim M., Mathia S., Persson P.B., Rosenberger Ch., Fähling M. Episodic Hypoxia Promotes Defence Against Cellular Stress. Cell Physiol Biochem., 2019, vol. 52, pp. 1075-1091, DOI:https://doi.org/10.33594/000000073.
6. Saprunova V.B., Solodovnokova I.M., Bakeeva L.E. Vyyavlenie citohrom s-oksidaznoy aktivnosti v mitohondriyah kardiimicitov izolirovannoy tkani miokarda pri dlitel'nom deystvii gipoksii. Citologiya, 2008, t. 50, № 3, c. 268-274. @@[Saprunova V.B., Solodovnikova I.M., Bakeeva L.E. The cytochrome c oxidase activity in mitochondria of cardiomyocytes of isolated cardiac tissue underlong-termhypoxic incubation. Tsitologiia, 2008, vol. 50, no. 3, pp. 268-274. (In Russ.)]
7. Vartapetian B.B., Andreeva I.N., Generozova I.P., Polyakova L.I., Maslova I.P., Dolgikh Y.I., Stepanova A.Y. Functional electron microscopy in studies of plant response and adaptation to anaerobic stress. Ann Bot., 2003, no. 91, pp. 155-172.
8. Kasumov E.A., Zaitseva M.G., Kasumova I.V., Senakhova M.A. Effect of valinomycin on respiration, changes of medium pH, and volume in mitochondria from mung bean hypocotyls. Russian plant physiology, 1993, vol. 40, no. 3, pp. 375-380.
9. Vyssokikh M.Y., Holtze S., Averina O.A., Lyamzaev K.G., Panteleeva A.A., Marey M.V., Zinovkin R.A., Severin F.F., Skulachev M.V., Fasel N., Hildebrandt T.B., Skulachev V.P. Mild depolarization of the inner mitochondrial membrane is a crucial component of an anti-aging program. Proc Natl Acad Sci USA., 2020, vol. 117, no. 12, pp. 6491-6501. DOI:https://doi.org/10.1073/pnas.1916414117.
10. Dröse S., Brandt U. The mechanism of mitochondrial superoxide production by the cytochrome bc1 complex. Jyu. Biol. Chem., 2008, vol. 283, no. 31, pp. 21649-54. DOI:https://doi.org/10.1074/jbc.M8032362001.
11. Kasumov E.A., Kasumov R.E., Kasumova I.V. A mechano-chemiosmotic model for the coupling of electron and proton transfer to ATP synthesis in energy-transforming membranes: a personal perspective. Photosynth Res., 2015, vol. 123, no. 1, pp. 1-22. DOI:https://doi.org/10.1007/s11120-014-0043-3.
12. Kasumov E.A., Kasumov R.E., Kasumova I.V. Mild depolarization of the inner mitochondrial membrane is a crucial component of the mechano-chemiosmotic mechanism of coupling. J. Nov. Physiother. Phys. Rehabil., 2020, vol. 7, no. 1, pp. 033-035. DOI: https://dx.doi.org/10.17352/2455-5487.000075.
13. Andrzejewski S., Gravel S-P., Pollak M., St-Pierre J. Metformin Directly Acts on Mitochondria to Alter Cellular Bioenergetics. Cancer Metab., 2014, vol. 2, no. 12. DOI:https://doi.org/10.1186/2049-3002-2-12.
14. Dehkordi A.H., Abbaszadeh A., Mir S., Hasanvand A. Metformin and its anti-inflammatory and anti-oxidative effects; new concepts. J. Renal. Inj. Prev., 2019, vol. 8, no.1, pp. 54-61. DOI:https://doi.org/10.15171/jrip.2019.11.
15. Kolosova, N.G., Vitovtov, A.O., Stefanova, N.A. Metformin reduces the signs of sarcopenia in old OXYS rats. Adv. Gerontol., 2016, vol. 6, pp. 70-74. DOI:https://doi.org/10.1134/S2079057016010069.
16. Emelyanova L., Gudlawar S., Cosic M., Mirza M., Rizvi F., Holmuhamedov E., Downey F., Tajik A., Jahangir A. Metformin Inhibits Mitochondrial Permeability Transition Pore Opening in Human Cardiac Mitochondria. Circulation Research., 2014, vol. 115, p. A322.
17. Kasumov E.A., Kasumov R.E., Kasumova I.V. On the MechanoChemiosmotic Mechanism of Action of Guanidinies on Functional Activity of Mitochondria and Aging. Organic Chem. Curr. Res., 2015, vol. 4, pp. 1-7. DOI:https://doi.org/10.4172/2161-0401.1000136.
18. Kasumov E.A., Kasumov R.E., Kasumova I.V. Mehanizm transformacii energii soglasno mehano-hemiosmoticheskoy modeli. Aktual'nye voprosy biologicheskoy fiziki i himii. BFFH-2019: mater. XIV mezhdunar. nauch. konf., 21-24 noyabrya g. Moskva, 2019, s. 94. @@[Kasumov E.A., Kasumov R.E., Kasumova I.V. Mechanism of energy transformation according to the mechano-chemiosmotic model. Modern Trends in Biological Physics and Chemistry. BPPC-2019: proceedings of XIV International Scientific Conference, Moscow, 2019, p. 94.]
19. Singh N.B., Shiva Saran Das, Singh A.K. Physical Chemistry: Volume II. New Age International Pvt Ltd Publishers, 2009, 579 p.
20. Kodera, N., Ando, T. The path to visualization of walking myosin V by high-speed atomic force microscopy. Biophys. Rev., 2014, vol. 6. no. 3-4, pp. 237-260.
21. Tominaga Y., Shimmen T., Tazawa M. Control of cytoplasmic streaming by extracellular Ca2+ in permeabilized Nitella cells. Protoplasma, 1983, vol. 116, pp. 75-77.
22. Zherelova O.M., Kataev A.A., Grischenko V.M., Shtanchaev R.Sh. Galoperidol-modulyator ionnogo transporta kletok Chara Corallina. Citologiya, 2016, t. 58, № 8, c. 646-654. @@[Zherelova O.M., Kataev A.A., Grischenko V.M., Shtanchaev R.S. Haloperidol modulates ionic transport of chara coralline cells. Tsitologia, 2016, vol. 58, no. 8, pp. 646-654. (In Russ.)]
23. Bridges H.R., Jones A.J., Pollak M.N., Hirst J. Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria. Biochem J., 2014, vol. 462, no. 3, pp. 475-487. DOI:https://doi.org/10.1042/BJ20140620.
24. Papa S., Tuena de Gómez-Puyou M., Gómez-Puyou A. On the mechanism of action of alkyl-guanidines on oxidative phosphorylation in mitochondria. Eur J Biochem., 1975, vol. 55, no. 1, pp. 1-8.
25. Heffernan K.S., Fahs C.A., Ranadive S.M., Patvardhan E.A. L-arginine as a nutritional prophylaxis against vascular endothelial dysfunction with aging. J Cardiovasc Pharmacol Ther., 2010, vol. 15, no. 1, pp. 17-23. DOI:https://doi.org/10.1177/1074248409354599.
26. Mitchell T.R., Glenfield K., Jeyanthan K., Zhu X.D. Arginine methylation regulates telomere length and stability. Mol Cell Biol., 2009, vol. 29, no. 18, pp. 4918-4934. DOI:https://doi.org/10.1128/MCB.00009-09P.
27. Böger R.H., Bode-Böger S.M., The clinical pharmacology of L-arginine. Annu. Rev. Pharmacol. Toxicol., 2001, vol. 41, pp. 79-99. DOI:https://doi.org/10.1146/annurev.pharmtox.41.1.79.
28. Wu G., Morris S.M., Jr. Arginine metabolism: nitric oxide and beyond. Biochem. J., 1998, vol. 336, pp. 1-17. DOI:https://doi.org/10.1042/bj3360001.
29. Mailoo VJ, Rampes S. Lysine for Herpes Simplex Prophylaxis: A Review of the Evidence. Integr. Med. (Encinitas), 2017, vol. 16, no.3, pp. 42-46.
30. Griffith R.S., Walsh D.E., Myrmel K.H., Thompson R.W., Behforooz A. Success of L-lysine Therapy in Frequently Recurrent Herpes Simplex Infection. Treatment and Prophylaxis. Dermatologica, 1987, vol. 175, no. 4, pp. 183-90.
31. Kobayashi N., Oka N., Mayumi M., Shimada K., Ishii A., Tatebayashi Y., Shigeta M., Yanagisawa H., Kondo K. Human Herpesvirus 6B Greatly Increases Risk of Depression by Activating Hypothalamic-Pituitary - Adrenal Axis during Latent Phase of Infection. iScience, 2020, vol. 23, no. 6. DOI:https://doi.org/10.1016/j.isci.2020.101187.
32. Itzhaki R.F. Corroboration of a Major Role for Herpes Simplex Virus Type 1 in Alzheimer’s Disease. Frontiers in Aging Neuroscience, 2018, vol. 10, no. 324. DOI:https://doi.org/10.3389/fnagi.2018.00324.
33. Kondadi A.K., Anand R., Hansch S., Urbach J., Zobel T., Wolf D.M., Segawa M., Liesa M., Shirihai O.S., Weidtkamp-Peters S., Reichert A.S. Cristae undergo continuous cycles of membrane remodelling in a MICOS-dependent manner. EMBO Rep., 2020, vol. 21, p. e49776. DOI:https://doi.org/10.15252/embr.201949776.
